505 related articles for article (PubMed ID: 1688087)
1. Mismatched double-stranded RNA, Ampligen (poly(I): poly(C12U), demonstrates antiviral and immunostimulatory activities in HIV disease.
Carter WA; Ventura D; Shapiro DE; Strayer DR; Gillespie DH; Hubbell HR
Int J Immunopharmacol; 1991; 13 Suppl 1():69-76. PubMed ID: 1688087
[TBL] [Abstract][Full Text] [Related]
2. Synergistic inhibition of AZT-resistant HIV by AZT combined with poly(I):poly(C12U), without synergistic toxicity to bone marrow progenitor cell elements.
Gillespie D; Hubbell HR; Carter WA; Midgette P; Elsasser W; Mullaney R; Strayer DR
In Vivo; 1994; 8(3):375-81. PubMed ID: 7803722
[TBL] [Abstract][Full Text] [Related]
3. Mismatched double-stranded RNA (ampligen) reduces concentration of zidovudine (azidothymidine) required for in-vitro inhibition of human immunodeficiency virus.
Mitchell WM; Montefiori DC; Robinson WE; Strayer DR; Carter WA
Lancet; 1987 Apr; 1(8538):890-2. PubMed ID: 2882293
[TBL] [Abstract][Full Text] [Related]
4. Dose-related effects of Ampligen (poly(I).poly(C12U)), a mismatched double-stranded RNA, in a bleomycin-mouse model of pulmonary fibrosis.
Wild JS; Hyde DM; Hubbell HR; Giri SN
Exp Lung Res; 1996; 22(3):375-91. PubMed ID: 8792127
[TBL] [Abstract][Full Text] [Related]
5. Mismatched double-stranded RNA: polyI:polyC12U.
Adis Editorial
Drugs R D; 2004; 5(5):297-304. PubMed ID: 15357629
[TBL] [Abstract][Full Text] [Related]
6. Ampligen inhibits human herpesvirus-6 in vitro.
Ablashi DV; Berneman ZN; Williams M; Strayer DR; Kramarsky B; Suhadolnik RJ; Reichenbach N; Hiltzges P; Komaroff AL
In Vivo; 1994; 8(4):587-91. PubMed ID: 7893986
[TBL] [Abstract][Full Text] [Related]
7. Mode of action of the anti-AIDS compound poly(I).poly(C12U) (Ampligen): activator of 2',5'-oligoadenylate synthetase and double-stranded RNA-dependent kinase.
Ushijima H; Rytik PG; Schäcke H; Scheffer U; Müller WE; Schröder HC
J Interferon Res; 1993 Apr; 13(2):161-71. PubMed ID: 8099601
[TBL] [Abstract][Full Text] [Related]
8. An hypothesis concerning optimal therapy in HIV disease.
Gillespie D; Carter WA
Med Hypotheses; 1992 Jan; 37(1):1-5. PubMed ID: 1569900
[TBL] [Abstract][Full Text] [Related]
9. The effect of combinations of ampligen and zidovudine or dideoxyinosine against human immunodeficiency viruses in vitro.
O'Marro SD; Armstrong JA; Asuncion C; Gueverra L; Ho M
Antiviral Res; 1992 Feb; 17(2):169-77. PubMed ID: 1554239
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of DNA topoisomerase I activity by 2',5'-oligoadenylates and mismatched double-stranded RNA in uninfected and HIV-1-infected H9 cells.
Schröder HC; Kelve M; Schäcke H; Pfleiderer W; Charubala R; Suhadolnik RJ; Müller WE
Chem Biol Interact; 1994 Feb; 90(2):169-83. PubMed ID: 8156606
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of HIV-1 proviral DNA synthesis and RNA accumulation by mismatched dsRNA.
Montefiori DC; Pellegrino MG; Robinson WE; Engle K; Field M; Mitchell WM; Gillespie DH
Biochem Biophys Res Commun; 1989 Feb; 158(3):943-50. PubMed ID: 2784055
[TBL] [Abstract][Full Text] [Related]
12. Results of a double-blind placebo-controlled study of the double-stranded RNA drug polyI:polyC12U in the treatment of HIV infection.
Thompson KA; Strayer DR; Salvato PD; Thompson CE; Klimas N; Molavi A; Hamill AK; Zheng Z; Ventura D; Carter WA
Eur J Clin Microbiol Infect Dis; 1996 Jul; 15(7):580-7. PubMed ID: 8874076
[TBL] [Abstract][Full Text] [Related]
13. Mismatched dsRNA (ampligen) induces protection against genomic variants of the human immunodeficiency virus type 1 (HIV-1) in a multiplicity of target cells.
Montefiori DC; Robinson WE; Mitchell WM
Antiviral Res; 1988; 9(1-2):47-55. PubMed ID: 2968777
[TBL] [Abstract][Full Text] [Related]
14. In vitro evaluation of mismatched double-stranded RNA (ampligen) for combination therapy in the treatment of acquired immunodeficiency syndrome.
Montefiori DC; Robinson WE; Mitchell WM
AIDS Res Hum Retroviruses; 1989 Apr; 5(2):193-203. PubMed ID: 2469450
[TBL] [Abstract][Full Text] [Related]
15. Clinical, immunological, and virological effects of ampligen, a mismatched double-stranded RNA, in patients with AIDS or AIDS-related complex.
Carter WA; Strayer DR; Brodsky I; Lewin M; Pellegrino MG; Einck L; Henriques HF; Simon GL; Parenti DM; Scheib RG
Lancet; 1987 Jun; 1(8545):1286-92. PubMed ID: 2884413
[TBL] [Abstract][Full Text] [Related]
16. Zidovudine and lamivudine: results of phase III studies.
Staszewski S
J Acquir Immune Defic Syndr Hum Retrovirol; 1995; 10 Suppl 1():S57. PubMed ID: 8595510
[TBL] [Abstract][Full Text] [Related]
17. [Biological actions and therapeutic perspectives of double stranded polyribonucleotides: a reappraisal].
Thang MN; Guschlbauer W
Pathol Biol (Paris); 1992 Dec; 40(10):1006-14. PubMed ID: 1284399
[TBL] [Abstract][Full Text] [Related]
18. [Are immunomodulators capable to improve the activity of nucleoside antiretroviral agents?].
Sinet M; Pocidalo JJ
Pathol Biol (Paris); 1993 Oct; 41(8 Pt 2):794-8. PubMed ID: 8309723
[TBL] [Abstract][Full Text] [Related]
19. A phase I study of ampligen in human immunodeficiency virus-infected subjects.
Armstrong JA; McMahon D; Huang XL; Pazin GJ; Gupta P; Rinaldo CR; Schoenfeld DA; Gaccione P; Tripoli CA; Bensasi S
J Infect Dis; 1992 Oct; 166(4):717-22. PubMed ID: 1527407
[TBL] [Abstract][Full Text] [Related]
20. Antiviral activity of biological response modifiers in a murine model of AIDS. Requirement for augmentation of natural killer cell activity and synergy with oral AZT.
Black PL; McKinnon KM; Wooden SL; Ussery MA
Int J Immunopharmacol; 1996 Nov; 18(11):633-50. PubMed ID: 9089007
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
